Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT01490827
Argus II retinal prosthesis system post-market surveillance study protocol
Argus II retinal prosthesis system post-market surveillance study protocol (Argus II PM-01-01).
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: No
Inclusion
- Opening Date: 2013-12-19
- Closing Date: 2019-09-04
Criteria
Inclusion: adults, age 25 or older, with severe to profound outer retinal degeneration causative of blindness
Exclusion: ocular diseases or conditions that could prevent Argus II from working (e.g. optic nerve disease, history of retinal detachment, trauma, severe strabismus, etc.)
Children: No
Adults: Yes
Funder Type: public
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
